Trending Articles

article thumbnail

Opinion: I study diet and chronic illness. Here’s the uncomfortable truth about seed oils

STAT

For decades, mainstream nutrition guidelines have recommended that Americans replace animal fats like butter or lard with polyunsaturated fats, especially seed oils such as soybean, corn, and sunflower oils. These oils are rich in omega-6 fatty acids and now make up a significant portion of the fat consumed in the standard American diet. But recently, the conversation has shifted.

294
294
article thumbnail

FDA sets stricter approval standards for COVID vaccines

BioPharma Dive

The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: I was a Theranos whistleblower. Here’s what I think Elizabeth Holmes is up to

STAT

I always knew Elizabeth Holmes would have a second act. But I’m shocked it’s starting while she’s still behind bars. Elizabeth is now serving an 11-year sentence for defrauding investors in Theranos and has been banned from participating in federal health programs. The company was built on her claim that, at 19 years old, she had invented a device capable of running hundreds of tests from just a single drop of blood.

361
361
article thumbnail

A new CFO tasked with taking ‘scrappy’ Editas from last year’s layoffs into new gene editing territory

PharmaVoice

Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.

147
147
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases

BioPharma Dive

A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.

119
119
article thumbnail

Pharmacies voted most accessible healthcare location

The Pharmacist

Community pharmacy was the most accessible healthcare location for the public last winter, ahead of general practice, dentists and hospital services, polling by YouGov has found. Almost six in 10 people who tried to access community pharmacies last winter found it easy to do so, compared to just four in 10 who could easily access […] The post Pharmacies voted most accessible healthcare location appeared first on The Pharmacist.

More Trending

article thumbnail

Duck Creek Technologies appoints Tyler Jones as chief marketing officer

Pharmafile

Duck Creek Technologies has appointed Tyler Jones as its new chief marketing officer (CMO). He will lead the companys global marketing strategy, supporting its position as a provider of property and casualty (P&C) insurance software. Jones brings more than two decades of experience at the intersection of insurance, technology and customer experience.

94
article thumbnail

EMCrit 1:1 Nursing 001 – An Easy Case of Sepsis

EMCrit Project

Our first episode uses a simple case to act as touch-point for a discussion of resus nursing in the ED. EMCrit Project by Scott Weingart, MD FCCM.

86
article thumbnail

AviadoBio opens UK trial for FTD gene therapy

Pharma Times

Aspire-FTD study aims to stop disease progression with one-time treatment

82
article thumbnail

STAT+: FDA commissioner says new vaccine ‘framework’ for industry is coming within weeks

STAT

WASHINGTON — Food and Drug Administration Commissioner Marty Makary said the agency is planning to unveil new guidance for vaccine makers, focused primarily on Covid-19 shots, in the coming weeks.  “We want to be very transparent, and we want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to worry,” Makary said at the Food and Drug Law Institute conference on Thursday.

Vaccines 314
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Drug Patent Research: Expert Tips for Using the FDA Orange and Purple Books

Drug Patent Watch

"Unlocking the Secrets of the FDA's Orange and Purple Books: Insider Tips from a Drug Patent Research Expert As the pharmaceutical industry continues to evolve at breakneck speed, staying ahead of the curve requires more than just a keen eye for innovation it demands a deep understanding of the regulatory landscape. For those in the know, the FDA's Orange and Purple Books hold the key to unlocking the secrets of the industry's most closely guarded information.

article thumbnail

FDA delays approval decision for Biohaven rare disease drug

BioPharma Dive

Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.

99
article thumbnail

Next‑Gen Pharma: AI, ML & Digital Twins Converge at AUTOMA+ 2025

Pharmaceutical Technology

The 5th Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) will gather industry leaders in Vsendorf, Austria on 24-25 November for indepth case studies, practical workshops and highimpact networking designed to accelerate pharmas digital journey.

86
article thumbnail

UnitedHealth CEO Chris Witty steps down

pharmaphorum

Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025

78
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

STAT+: As AI in health care proliferates, so do legal questions concerning its use

STAT

SAN FRANCISCO — Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues. Chief among them: a lack of consent from patients, whether any doctor checks the machine’s work, and, if they do, whether that even helps.  A panel of legal and medical experts at STAT’s Breakthrough Summit West explained the myriad legal questions hanging over the adoption of AI in health care.

article thumbnail

Delivering NHS pharmacy services 'could pay for a new staff member'

The Pharmacist

Delivering nationally-commissioned NHS pharmacy services could generate enough income to pay the wages of an additional staff member, Community Pharmacy North East London chief executive has suggested. Delivering just 20 NHS consultations each week could generate as much as 451.70, Shilpa Shah told contractors this week at the Sigma 2025 conference in Baku, Azerbaijan.

article thumbnail

Barentz acquires Fengli, China, aims to strengthen market presence

Express Pharma

Barentz, a specialty ingredients solutions provider, has entered into exclusive discussions to acquire 100 per cent equity of Fengli Group, a specialty chemicals distributor for pharmaceutical excipients and active ingredients in China. Established in 1996 and headquartered in Beijing, Fengli Group comprises a team of over 100 experienced professionals across five locations in mainland China.

66
article thumbnail

AbbVie stakes $335M on a startup’s RNAi drugs

BioPharma Dive

ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including neurology, immunology and cancer.

64
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Sanofi pledges a $20 billion investment programme in the US

pharmaphorum

Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US

69
article thumbnail

STAT+: In combative hearings, Kennedy defends HHS cuts, backtracks — and lashes out

STAT

WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.

311
311
article thumbnail

Prescribing Red Flags: Pharmacists Be Wary of What the Doctor Orders

FDA Law Blog: Biosimilars

By Larry K. Houck Last month the U.S. Attorneys Office for the Northern District of Illinois announced that Walgreens agreed to pay up to $350,000,000 to resolve allegations that its pharmacies illegally filled millions of invalid prescriptions for opioids and other controlled substances in violation of the federal Controlled Substances Act, and sought payment for filling many of those prescriptions by federal health care programs, violating the False Claims Act.

article thumbnail

STEERLife announces its solvent-free melt fusion technology

Express Pharma

STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. At the core of this advancement is STEERLife’s solvent-free melt fusion technology, a continuous processing system that eliminates the need for harmful organic solvents. Designed to handle high-potency and hard-to-develop molecules, this platform significantly enhances formulation efficiency, safety, and scalability.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Pharmaceutical Marketing Strategies that Truly Connect with HCPs

Pharma Marketing Network

Imagine youre trying to reach a specialist in a bustling hospitalyour message is a whisper in a sea of noise. How do you get through? In the complex world of healthcare, pharmaceutical marketing strategies must evolve to genuinely connect with healthcare professionals (HCPs). No longer effective are blanket tactics or generic messaging. Instead, today’s successful marketers are leveraging personalized, data-driven, and omnichannel approaches that meet HCPs where they are.

article thumbnail

AbbVie bags first approval for cancer ADC Emrelis

pharmaphorum

AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis

66
article thumbnail

New FDA framework on Covid vaccines leaves pediatricians confused and concerned

STAT

A new framework for Covid-19 vaccines announced by Food and Drug Administration leaders Tuesday suggests the agency will no longer approve new Covid vaccines for healthy individuals under 65, including babies, without data from new randomized clinical trials showing their benefit.  The plan — described in a commentary in the New England Journal of Medicine, followed by a live stream on YouTube — created confusion among physicians about what it means for young children.

Vaccines 246
article thumbnail

Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff

BioPharma Dive

Tourmaline Bio disclosed results for a potential rival to a Novo Nordisk drug. Elsewhere, data emerged for a psychedelic and CRISPR Therapeutics expanded its toolkit.

59
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Lupin gains USFDA approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Express Pharma

Lupin announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg. Rivaroxaban Tablets are bioequivalent to Xarelto Tablets, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals. This product will be manufactured at Lupins Aurangabad facility in India.

66
article thumbnail

Themes Among Rare Disease Repurposing Efforts

Pharmaceutical Commerce

A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.

59
article thumbnail

O'Shaughnessy says UK clinical trials sector is on the mend

pharmaphorum

After losing ground in commercial clinical trials in recent years, the UK has now turned a corner and is once again taking a "global lead"

59
article thumbnail

STAT+: Mental health apps can boost outcomes and lower costs, study finds

STAT

Developers of digital mental health treatments now have fresh economic data to help make the case for broader coverage of their apps. Companies selling Food and Drug Administration-cleared apps for the treatment of psychiatric and other conditions have long struggled with adoption by patients, providers, and payers for many reasons. Clinical evidence supporting these prescription digital therapeutics has gradually improved , but policymakers and insurers have been hesitant to open the path to re

268
268
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.